AITB
Beyond Air is a clinical-stage medical device and biopharmaceutical company focused on leveraging nitric oxide to treat respiratory and other diseases. The company develops the LungFit technology to generate nitric oxide on demand, aiming to provide inhaled therapy from hospital settings to home use. Its product pipeline includes medical devices and related therapies designed to improve access to nitric oxide treatment worldwide. Headquartered in the United States, Beyond Air emphasizes innovation in nitric oxide delivery and regulatory-compliant solutions across care settings.
No recent news for this company.
No recent deals for this company.